Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group

We report the results of the national multicenter trial of cryotherapy for retinopathy of prematurity, as determined 3 months after randomization. The threshold severity of retinopathy required for entry into the clinical trial was defined as five or more contiguous or eight cumulative 30 degree sectors (clock hours) of stage 3+ retinopathy of prematurity in zone 1 or 2. Transscleral cryotherapy to the avascular retina was applied in one eye when there was threshold retinopathy in both eyes, or in half the eyes when the threshold severity existed in only one eye (18% of patients). Of the 279 infants who survived 3 months following randomization, 273 returned for outcome examination at that time. Of these infants, 260 had fundus photographs taken that could be graded for anatomic outcome. An unfavorable outcome was defined as posterior retinal detachment, posterior retinal fold (usually involving the macula), or retrolental tissue that obscured the view of the posterior pole. Whereas 51.4% of control eyes had an unfavorable outcome, this was significantly less frequent in the eyes that received cryotherapy (31.1%). No deaths were attributed to the cryotherapy procedure. These data, together with numerous additional ocular findings and preliminary 12-month postrandomization outcome results reported herein, support the efficacy of cryotherapy in reducing the risk of unfavorable ocular outcome from threshold retinopathy of prematurity. We have previously recommended cryotherapy for at least one eye in all patients with threshold retinopathy of prematurity. Now we add the recommendation cryotherapy be considered for both eyes whenever stage 3+ retinopathy of prematurity involves the posterior retina (zone 1) of both eyes.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinopathy of Prematurity in Bangladeshi Neonates
Ahmed et al.
J Trop Pediatr 2008;54:333-339.
ABSTRACT | FULL TEXT  

Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies
Holmstrom et al.
Br. J. Ophthalmol. 2007;91:1704-1708.
ABSTRACT | FULL TEXT  

Progression to Severe Retinopathy Predicted by Retinal Vessel Diameter Between 31 and 34 Weeks of Postconception Age
Rabinowitz et al.
Arch Ophthalmol 2007;125:1495-1500.
ABSTRACT | FULL TEXT  

Impact of the Cryotherapy for Retinopathy of Prematurity Randomized Clinical Trial
Flynn
Arch Ophthalmol 2007;125:1275-1276.
FULL TEXT  

Evaluating the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP)
Mills
Arch Ophthalmol 2007;125:1276-1281.
FULL TEXT  

Genetic Influences on Susceptibility to Oxygen-Induced Retinopathy
van Wijngaarden et al.
IOVS 2007;48:1761-1766.
ABSTRACT | FULL TEXT  

The Boer War and fuzzy logic in screening.
Clarke
Br. J. Ophthalmol. 2006;90:400-401.
FULL TEXT  

Visual Acuity at 10 Years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Study Eyes: Effect of Retinal Residua of Retinopathy of Prematurity.
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2006;124:199-202.
ABSTRACT | FULL TEXT  

Near Confluent Laser Photocoagulation for the Treatment of Threshold Retinopathy of Prematurity
Rezai et al.
Arch Ophthalmol 2005;123:621-626.
ABSTRACT | FULL TEXT  

15-Year Outcomes Following Threshold Retinopathy of Prematurity: Final Results From the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2005;123:311-318.
ABSTRACT | FULL TEXT  

Health-Related Quality of Life at Age 10 Years in Very Low-Birth-Weight Children With and Without Threshold Retinopathy of Prematurity
CRYO-ROP Cooperative Group
Arch Ophthalmol 2004;122:1659-1666.
ABSTRACT | FULL TEXT  

Refraction and keratometry in 40 week old premature (corrected age) and term infants
Snir et al.
Br. J. Ophthalmol. 2004;88:900-904.
ABSTRACT | FULL TEXT  

Continuing Care of NICU Graduates
Verma et al.
CLIN PEDIATR 2003;42:299-315.
 

Can Changes in Clinical Practice Decrease the Incidence of Severe Retinopathy of Prematurity in Very Low Birth Weight Infants?
Chow et al.
Pediatrics 2003;111:339-345.
ABSTRACT | FULL TEXT  

Evidence-Based Screening Criteria for Retinopathy of Prematurity: Natural History Data From the CRYO-ROP and LIGHT-ROP Studies
Reynolds et al.
Arch Ophthalmol 2002;120:1470-1476.
ABSTRACT | FULL TEXT  

Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Natural History ROP: Ocular Outcome at 51/2 Years in Premature Infants With Birth Weights Less Than 1251 g
Editorial Committee; for Cryotherapy for Retinopat
Arch Ophthalmol 2002;120:595-599.
ABSTRACT | FULL TEXT  

Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Ophthalmological Outcomes at 10 Years
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2001;119:1110-1118.
ABSTRACT | FULL TEXT  

Effect of Retinal Ablative Therapy for Threshold Retinopathy of Prematurity: Results of Goldmann Perimetry at the Age of 10 Years
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2001;119:1120-1125.
ABSTRACT | FULL TEXT  

Contrast Sensitivity at Age 10 Years in Children Who Had Threshold Retinopathy of Prematurity
Cryotherapy for Retinopathy of Prematurity Coopera
Arch Ophthalmol 2001;119:1129-1133.
ABSTRACT | FULL TEXT  

Ten-Year Follow-up From the CRYO-ROP Study
Tasman
Arch Ophthalmol 2001;119:1200-1201.
FULL TEXT  

Iris Atrophy, Cataracts, and Hypotony Following Peripheral Ablation for Threshold Retinopathy of Prematurity
Kaiser and Trese
Arch Ophthalmol 2001;119:615-617.
FULL TEXT  

Screening for Retinopathy of Prematurity Employing the RetCam 120: Sensitivity and Specificity
Roth et al.
Arch Ophthalmol 2001;119:268-272.
ABSTRACT | FULL TEXT  

Diode laser treatment of posterior retinopathy of prematurity
Axer-Siegel et al.
Br. J. Ophthalmol. 2000;84:1383-1386.
ABSTRACT | FULL TEXT  

Does Candidemia Predict Threshold Retinopathy of Prematurity in Extremely Low Birth Weight (<= 1000 g) Neonates?
Karlowicz et al.
Pediatrics 2000;105:1036-1040.
ABSTRACT | FULL TEXT  

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes
The STOP-ROP Multicenter Study Group
Pediatrics 2000;105:295-310.
ABSTRACT | FULL TEXT  

Screening for retinopathy of prematurity: no ophthalmologist required?
GOOD
Br. J. Ophthalmol. 2000;84:127-128.
FULL TEXT  

Cost-Effectiveness of Treatment for Threshold Retinopathy of Prematurity
Brown et al.
Pediatrics 1999;104:47e-47.
ABSTRACT | FULL TEXT  

Dopamine use is an indicator for the development of threshold retinopathy of prematurity
Mizoguchi et al.
Br. J. Ophthalmol. 1999;83:425-428.
ABSTRACT | FULL TEXT  

Longer term visual outcome of eyes with retinopathy of prematurity treated with cryotherapy or diode laser
O'Keefe et al.
Br. J. Ophthalmol. 1998;82:1246-1248.
ABSTRACT | FULL TEXT  

Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser
Pearce et al.
Br. J. Ophthalmol. 1998;82:1254-1259.
ABSTRACT | FULL TEXT  

Limbus-Based External Reference Coagulation in Transscleral Diode Laser Photocoagulation for Threshold Retinopathy of Prematurity
Arnold et al.
Arch Ophthalmol 1998;116:1404-1404.
FULL TEXT  

Should Fewer Premature Infants Be Screened for Retinopathy of Prematurity in the Managed Care Era?
Wright et al.
Pediatrics 1998;102:31-34.
ABSTRACT | FULL TEXT  

Strabismus in Premature Infants in the First Year of Life
Bremer et al.
Arch Ophthalmol 1998;116:329-333.
ABSTRACT | FULL TEXT  

Screening Examination of Premature Infants for Retinopathy of Prematurity
Fierson et al.
Pediatrics 1997;100:273-274.
FULL TEXT  

Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study
Laws et al.
Br. J. Ophthalmol. 1997;81:12-15.
ABSTRACT | FULL TEXT